“Comparative Study Between Combination Therapy Empagliflozin–Sitagliptin and Empagliflozin–Alogliptin in Addition to Metformin Assessing the Hypoglycemic Effect on Patients Diagnosed With Malignancy and Poorly Controlled Type 2 Diabetes Mellitus As Comorbidity”. 2025. Journal of Carcinogenesis 24 (3): 669-74. https://doi.org/10.64149/J.Carcinog.24.3.669-674.